TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+5.28%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.69B
AUM Growth
+$2.69B
(+12%)
Cap. Flow
+$181M
Cap. Flow
% of AUM
6.73%
Top 10 Holdings %
Top 10 Hldgs %
49.42%
Holding
121
New
19
Increased
15
Reduced
14
Closed
13
Top Buys
| 1 |
Viatris
VTRS
|
$56.1M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$53.5M |
| 3 |
Johnson & Johnson
JNJ
|
$43.9M |
| 4 |
Alkermes
ALKS
|
$28.8M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$23M |
Top Sells
| 1 |
AbbVie
ABBV
|
$71.2M |
| 2 |
Gilead Sciences
GILD
|
$23.4M |
| 3 |
Perrigo
PRGO
|
$21.6M |
| 4 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$19.4M |
| 5 |
Heron Therapeutics
HRTX
|
$13.6M |
Sector Composition
| 1 | Healthcare | 86.5% |
| 2 | Real Estate | 3.17% |
| 3 | Financials | 1.57% |
| 4 | Technology | 0.04% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Baxter International
BAX
$12.1B
| $22.4M | 0.81% |
319,600
| – | – |
|
27
Humana
HUM
$37.5B
| $21.4M | 0.78% |
+112,000
| New | +$21.4M |
|
28
iShares Biotechnology ETF
IBB
$5.68B
| $21.3M | 0.77% |
57,670
| – | – |
|
29
Jazz Pharmaceuticals
JAZZ
$7.99B
| $21.2M | 0.77% |
120,357
-384
| -0.3% | -$67.6K |
|
30
HCA Healthcare
HCA
$95.4B
| $19.4M | 0.7% |
213,788
+66,300
| +45% | +$6.01M |
|
31
Ventas
VTR
$30.7B
| $18.2M | 0.66% |
292,782
| – | – |
|
32
Neurocrine Biosciences
NBIX
$13.5B
| $18M | 0.65% |
375,860
-125,290
| -25% | -$5.98M |
|
|
PRTK
33
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $17.8M | 0.64% |
+691,000
| New | +$17.8M |
|
|
DOC
34
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $16.1M | 0.58% |
1,050,902
| – | – |
|
|
IPXL
35
DELISTED
Impax Laboratories, Inc.
IPXL
| $15.8M | 0.57% |
344,683
| – | – |
|
|
ALR
36
DELISTED
Alere Inc
ALR
| $15.7M | 0.57% |
297,901
| – | – |
|
37
Acadia Pharmaceuticals
ACAD
$4.34B
| $15.5M | 0.56% |
+370,000
| New | +$15.5M |
|
38
McKesson
MCK
$85.9B
| $15.3M | 0.55% |
67,862
| – | – |
|
39
Medical Properties Trust
MPW
$2.66B
| $15.1M | 0.55% |
1,153,574
| – | – |
|
40
Omega Healthcare
OHI
$12.5B
| $14.2M | 0.51% |
413,116
| – | – |
|
|
41
Heron Therapeutics
HRTX
$204M
| $13.6M | 0.49% |
436,970
-436,970
| -50% | -$13.6M |
|
42
Community Health Systems
CYH
$392M
| $13.2M | 0.48% |
209,572
| – | – |
|
43
Karyopharm Therapeutics
KPTI
$61.4M
| $13M | 0.47% |
476,966
| – | – |
|
44
Alnylam Pharmaceuticals
ALNY
$58.6B
| $12.4M | 0.45% |
103,495
-26,700
| -21% | -$3.2M |
|
45
Esperion Therapeutics
ESPR
$490M
| $12.1M | 0.44% |
+148,000
| New | +$12.1M |
|
46
Cigna
CI
$80.2B
| $12M | 0.44% |
74,251
| – | – |
|
|
WELL.PRI
47
DELISTED
Welltower Inc.
WELL.PRI
| $11.9M | 0.43% |
200,000
| – | – |
|
48
Stryker
SYK
$149B
| $11.8M | 0.43% |
123,940
| – | – |
|
|
STJ
49
DELISTED
St Jude Medical
STJ
| $11.8M | 0.43% |
161,510
| – | – |
|
50
Sabra Healthcare REIT
SBRA
$4.56B
| $11.7M | 0.42% |
456,190
| – | – |
|